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Crohn’s involvement of the Vulva is unfamiliar and difﬁcult to treat. The aim is to review the presentation,
clinical course and different treatments of Vulva Crohn’s disease (CD). We have reviewed the literature
without language barrier from 1966 to 2009 through Pubmed with the following words: vulva and CD,
vulvitis and CD, genital CD. We included articles that had Crohn’s involvement of the vulva arising from
a distant site (metastatic) or arising from a Crohn’s ﬁstula from the perineum and/or anorectum. We
excluded CD of other gynaecological organs. One hundred thirty six abstracts were identiﬁed and related
articles reviewed. Fifty-ﬁve cases of CD of the vulva were included in the ﬁnal anlaysis of this review.
Vulva involvement is rare and gives long-term discomfort. A combined medical therapy (metronidazole
with prednisolone) appears to be the most effective treatment. The surgical approach should be reserved
for non-responding cases. CD is often unrecognized cause of vulva pain and difﬁcult to diagnose. However
if diagnosed and adequately treated it usually responds to conservative therapies.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Crohn’s disease (CD) is a chronic inﬂammatory granulomatous
disorder that may affect any part of the gastrointestinal tract and is
often associated with extra intestinal manifestations. It can present
with signs and symptoms of bowel inﬂammation with or without
the presence of ﬁstulas/abscesses, or as a distant lesion indepen-
dent from the affected bowel. Involvement of gynaecological
organs is often unrecognized and misdiagnosed. Due to the lack of
knowledge concerning gynaecological aspects of CD, patients are
usually are not correctly managed and undergo inappropriate
treatments.1
Rectovaginal ﬁstulas and ovarian involvement of CD have been
extensively described.2,3 However there are only few series in the
literature reporting genital complications of CD and even less so
regarding vulva involvement of CD. Aim of this paper is to
describe the different presentations, complications, courses and
treatments of the rare presentation of CD of the vulva in
a systematic manner.2. Materials and methods
A literature search was carried out without language barrier
from 1966 to January 2009 through Pubmed using the key words:180.
. Andreani).
ciates Ltd. Published by Elsevier Ltvulva and Crohn’s disease, vulvitis and Crohn’s disease, vulvovagi-
nal Crohn’s disease, genital Crohn’s disease. A further research was
performed on the basis of the reference and links of these papers.
All articles were assessed by ASM, DHH and RK. Inclusion criteria
was the presence of vulval CD arising from a distant site (meta-
static) or ﬁstulating from the perineum and/or anorectum. Articles
reporting on CD of the vagina or other gynaecological organ
involvement were excluded.3. Results
136 relevant articles were identiﬁed. After reading the title and
the abstract 50 papers containing in total 55 cases were selected
and reviewed.
Parks et al.4 described the ﬁrst vulva involvement of CD in 1965
and since then, 54 further cases have been reported in literature.
One article in Czech language5 was not included in the review as we
were unable to translate it.3.1. Presentation
The age of presentation varied from 12 to 64 years of age with
a mean age of 34. Nearly two thirds of the cases were pre-
menopausal women. However no meaningful conclusions can be
drawn from this fact as the number of cases in this study was too
small.d. All rights reserved.
Table 1
Symptoms at presentation.
Swelling Ulcers Pain Pruritis Erythema Abscess Discharge Mass
Total patients (percentage) 34(61.8%) 22(40.7%) 11(20.3%) 7(12.9%) 8(14.5%) 2(3.7%) 3(5.5%) 2(3.7%)
References describing the different symptoms and signs at presentation.
Table 2
Medical treatments.
Oral
Metronidazole
Oral metronidazole
and prednisolone
Other medical
treatment b
Total No. of cases
(Successfully
treated)
14(10) 8(7) 23(14)
% Of successful
treatment
71.4% 87.5% 60.9%
b– 9,11,13,14,19,21–23,25,30,32,34,35,41,43–47,51.
References that described a successful medical therapy.
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diagnose, especially in cases of metastatic spread rather than direct
or contiguous spread such as from ﬁstula formation. In our review,
metastatic spreadwas by far themost commonpresentation, 91% of
cases (50 patients),6–47 while contiguous spread occurred in only
9% of the cases (5 patients).40,48–51
The length or speciﬁc ‘type’ of previous active Crohn’s disease
was not identiﬁed to predispose patients to CD of the vulva.
Interestingly, 25% of vulva CD did not have any previous intestinal
symptoms and had not been diagnosed with CD at the time of their
vulva symptoms.6,8,10,11,17,20,25,29,30,36,40,45,52 Vulva involvement
represented the ﬁrst and/or only manifestation of disease.
Furthermore, vulva CD can appear many years after a subtotal
colectomy in patients with evidence of no other CD49 or can persist
despite excision of the intestinal disease or quiescent gastrointes-
tinal disease.42
3.1.1. Signs and symptom
Vulva CD typically manifests with swelling, pruritus, erythema
and as a progressive and painful ulceration of the labia. These can
often evolve into condyloma-like lesions and/or skin tags. Patients
can also present a wide range of symptoms such as vaginal
discharge, painful ulcerations or a vulva mass (Table 1). Physical
examination usually revealed an indurated area, localized or
generalized oedema of the labia and ulcers that often extended into
the groin. The duration of the symptoms varied from 1 to 18
months in this review. These signs and symptoms are also common
to many other gynaecological conditions making the clinical
suspicion of vulva CD very difﬁcult. This results in delayed deﬁni-
tive diagnoses.
3.1.2. Diagnosis
When these clinical features are identiﬁed, it is important to
exclude other granulomatous disease such as sarcoidosis, tubercu-
losis, lymphogranulomavenereum,pyogenic infections, hidradenitis
suppurativa, intertrigo and syphilitic lesions. A biopsy of the lesion is
necessary to achieve the deﬁnitive diagnosis. In our review, 93% of
patientswere biopsied; and the histology in all of these revealed the
typical appearanceof anon-caseatinggranulomatous lesionas found
in CD.
3.1.3. Treatment
This review ﬁnds that the natural course of vulva CD to be
unpredictable. Some lesions may resolve spontaneously,31 others
appear to be particular resistant to the medical treatment and
require surgery treatment.
The treatment of vulva CD relies mainly on medical therapy; in
this review 42 (76.4%) of the reported cases received medical
therapy and 17 (30.9%) underwent surgical procedures either after
failing medical treatment (9 cases)7,12,28,41,42,49,51 or as ﬁrst line
(8 cases).7,17,24,33,39,40 One out of the 55 patients refused either
medical or surgical treatment.50
Numerous medical regimens have been suggested (Table 2).
Most authors reported a signiﬁcant improvement with metroni-
dazole alone7,8,10,11,14,15,27,30,37,45,47,48,52 or in conjunction with oral
or topical steroids.22,26,28,29,36,38,42,44 Seventeen out of 22 cases
(77.3%) that received metronidazole showed signiﬁcant improve-
ment. Only 5 cases failed; one had a ﬁstula,48 one had an extensivedisease that recurred also after the surgical excision,28 one
improved after prednisolone and mesalazine,30 one improved with
combined inﬂiximab and azathiprine treatment47 and in the ﬁfth
case the follow up was not reported.45 The long-term use of
metronidazole was associated with bilateral pedal parasthesia in 2
of the cases,20,53 whether this side effect resolved on discontinuing
metronidazole was not reported. Sudden discontinuation of
metronidazole was reported in 3 cases to cause exacerbation of the
vulva symptoms.20,38,53 Disappointing results were obtained with
the use of other antibacterial agents with high recurrence rates as
shown in 3 cases.13,20,41
In this review surgery was carried out in 17 patients. Indi-
cations for surgery were either failure to respond to medical
treatment (9 cases) or as ﬁrst line (7 cases) as decided by the
attending clinician. Only 10 of the 17 surgically treated patients
(58.8%) improved as shown in Table 3. The follow up time
period following surgery were not stated in most cases. Surgical
debridement of perianal CD was shown to be beneﬁcial in those
patients with co existing abscess of the vulva.7 Disappointing
results were achieved with localized surgical excision, with only
412,33,39,42 out of 11 cases being successful. In the other 7
cases7,14,17,21,28,40,41 local excisions resulted in localized recur-
rences or non-healing of the wounds. Vulvectomy was necessary
for a more deﬁnitive treatment in 4 patients24,41,49,51; one of
which was due coexisting diseases of Bowen’s carcinoma.49 All
of these 4 cases had good wound healing.4. Comments
Vulva involvement from CD is very rare and mostly due to
distant spread (metastatic). Diagnosis is difﬁcult due to the rarity of
the condition and the great variety of signs and symptoms. The
difﬁculty is also due to the fact that 25% of these patients do not
have gastrointestinal symptoms of CD and thus clinicians need to
be vigilant.
Differential diagnosis includes sarcoidosis, tuberculosis, lympho-
granuloma venereum, pyogenic infections, hidradenitis suppurativa,
intertrigo and syphilitic lesions. Deﬁnitive diagnosis can only
be achieved by biopsy which would reveal a non-caseating granu-
lomatous lesion.
Metronidazole alone or in combination with Prednisolone
seems to be the most effective with a success rate of 87.5%. Surgical
treatment is only reserved for a few cases as disﬁgurement of the
site can cause great deal of psychological stress to the patient. This
review showed that local excision was not successful due to
Table 3
Results of Surgical Treatment.
References Surgical Treatment
Local excision Total Vulvectomy Incision & Drainage
Total No. of cases
(Successfully
treated)
11(4) 4(4) 2(2)
Successful (%) 36% 100% 100%
Results after surgery.
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medical treatment vulvectomy was successful with low morbidity.
Incision and drainage was also found to be useful in cases which
involved the presences of abscess.
It is clear TNF and antibody suppresors have revolutionised the
treatment of Crohn’s Disease. However vast majority of the cases in
this review were published before the establishment of such
treatment. There is only one case which reports the use of
inﬂiximab47; which was successful in resolving the symptoms.
Therefore no meaningful conclusions can be drawn regarding the
use of such treatment in CD of the vulva.
It can be concluded that surgical treatment should not be the
ﬁrst line of treatment but used in carefully picked cases where
other treatment had failed. As symptoms are gynaecological in
nature patients will probably present to gynaecologists. CD is not
often seen in this speciality and thus a greater awareness is needed.
Once the diagnosis is made a multi-team approach with gastro-
enterologist or colorectal surgeon must be taken with the ﬁrst line
of treatment being medical therapy.
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